Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Gifiber
- Development stage
- Unknown
- Lead developer
- Auriga Laboratories
- Modality
- Microbiome Therapeutics
- Administration
- Oral
01
Overview
Gifiber is a dietary fiber supplement and bulk-forming laxative marketed by Auriga Laboratories. Typically packaged in a 180g formulation, it is used to support gastrointestinal health, promote bowel regularity, and relieve constipation. As a fiber-based product, it works by absorbing water in the intestines, increasing stool bulk and moisture to facilitate easier passage.
- Brand names
- GIFIBER 180GGIFIBER180GGIFIBER-180GGifiber
Beyond the preview
Go deeper on Gifiber.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Gifiber.